IL1B and breast carcinoma: In a more recent study exploring mechanisms of drug resistance in breast cancer cells, it was demonstrated that inflammation in tissues leads to the upregulation of IL-1B and, subsequently, ΔNp63, which upregulates the expression of growth factors and downregulates the expression of DNA damage sensors, leading to drug resistance and the progression of breast cancer [185].